Genmab A (GMAB) Tax Provisions (2024 - 2026)
Genmab A's (GMAB) quarterly Tax Provisions came in at $136.0 million in Q2 2025, down 15.53% YoY from $161.0 million in Q2 2024, and down 15.53% on a QoQ basis from $161.0 million in Q2 2024.
Genmab A (GMAB) Tax Provisions (2024 - 2026) Analysis & Trends
Genmab A (GMAB) has 2 years of Tax Provisions data on file, last reported at $136.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Genmab A | 2.05 Bn | 548.77 Mn | 1.07 Bn | -8.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.00 Mn |
| Mar 31, 2026 | -1.00 Mn |
| Jun 30, 2025 | 136.00 Mn |
| Jun 30, 2024 | 161.00 Mn |